MeningiomaSymptoms, Doctors, Treatments, Advances & More
Learn About Meningioma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Stephen Magill is a Neurosurgery provider practicing medicine in Chicago, Illinois. He has been practicing medicine for over 13 years. Dr. Magill is rated as an Elite provider by MediFind in the treatment of Meningioma. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Meningioma, Schwannoma, Brain Tumor, Rhizotomy, and Awake Craniotomy. Dr. Magill is board certified in American Board Of Neurological Surgery - Neurological Surgery (Certified).
UPMC Neurological Institute - Presbyterian
Dr. Gardner is the Peter J. Jannetta Endowed Chair of neurological surgery at the University of Pittsburgh School of Medicine and director of the Center for Skull Base Surgery. He specializes in endoscopic endonasal skull base surgery, pituitary tumors, Neuroendoport brain surgery, and vascular neurosurgery. Dr. Gardner is rated as an Elite provider by MediFind in the treatment of Meningioma. He is also highly rated in 61 other conditions, according to our data. His clinical expertise encompasses Chordoma, Pituitary Tumor, Meningioma, Nerve Decompression, and Endoscopic Transnasal Transsphenoidal Surgery. Dr. Gardner is board certified in American Board Of Neurological Surgery. Dr. Gardner is currently accepting new patients.
Weill Cornell Medicine
Susan Pannullo is a Neurologist and a Neurosurgery provider practicing medicine in New York, New York. Dr. Pannullo is rated as an Elite provider by MediFind in the treatment of Meningioma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Meningioma, Acoustic Neuroma, Metastatic Brain Tumor, and Brain Tumor. Dr. Pannullo is board certified in American Board Of Psychiatry And Neurology. Dr. Pannullo is currently accepting new patients.
Summary: This is an open-label, multicenter, randomized, phase 2 clinical study to evaluate the efficacy of \[177Lu\]Lu-DOTATATE in patients with progressive grade 1-3 intracranial meningioma.
Summary: Study in children and adolescents of 177Lu DOTATATE (Lutathera®) combined with the PARP inhibitor olaparib for treatment of recurrent or relapsed solid tumours expressing somatostatin receptors (SSTR) (LuPARPed)